• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝门部胆管癌肝切除术后的死亡率:风险评分的制定及未来肝残余量胆汁引流的重要性

Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant.

作者信息

Wiggers Jimme K, Groot Koerkamp Bas, Cieslak Kasia P, Doussot Alexandre, van Klaveren David, Allen Peter J, Besselink Marc G, Busch Olivier R, D'Angelica Michael I, DeMatteo Ronald P, Gouma Dirk J, Kingham T Peter, van Gulik Thomas M, Jarnagin William R

机构信息

Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.

Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

J Am Coll Surg. 2016 Aug;223(2):321-331.e1. doi: 10.1016/j.jamcollsurg.2016.03.035. Epub 2016 Apr 5.

DOI:10.1016/j.jamcollsurg.2016.03.035
PMID:27063572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4961586/
Abstract

BACKGROUND

Liver surgery for perihilar cholangiocarcinoma (PHC) is associated with postoperative mortality ranging from 5% to 18%. The aim of this study was to develop a preoperative risk score for postoperative mortality after liver resection for PHC, and to assess the effect of biliary drainage of the future liver remnant (FLR).

STUDY DESIGN

A consecutive series of 287 patients submitted to major liver resection for presumed PHC between 1997 and 2014 at 2 Western centers was analyzed; 228 patients (79%) underwent preoperative drainage for jaundice. Future liver remnant volumes were calculated with CT volumetry and completeness of FLR drainage was assessed on imaging. Logistic regression was used to develop a mortality risk score.

RESULTS

Postoperative mortality at 90 days was 14% and was independently predicted by age (odds ratio [OR] per 10 years = 2.1), preoperative cholangitis (OR = 4.1), FLR volume <30% (OR = 2.9), portal vein reconstruction (OR = 2.3), and incomplete FLR drainage in patients with FLR volume <50% (OR = 2.8). The risk score showed good discrimination (area under the curve = 0.75 after bootstrap validation) and ranking patients in tertiles identified 3 (ie low, intermediate, and high) risk subgroups with predicted mortalities of 2%, 11%, and 37%. No postoperative mortality was observed in 33 undrained patients with FLR volumes >50%, including 10 jaundiced patients (median bilirubin level 11 mg/dL).

CONCLUSIONS

The mortality risk score for patients with resectable PHC can be used for patient counseling and identification of modifiable risk factors, which include FLR volume, FLR drainage status, and preoperative cholangitis. We found no evidence to support preoperative biliary drainage in patients with an FLR volume >50%.

摘要

背景

肝门部胆管癌(PHC)肝切除术的术后死亡率为5%至18%。本研究的目的是制定PHC肝切除术后的术前死亡风险评分,并评估未来肝残余(FLR)胆道引流的效果。

研究设计

分析了1997年至2014年期间在2个西方中心接受疑似PHC大肝切除术的287例连续患者;228例患者(79%)因黄疸接受了术前引流。采用CT容积测量法计算未来肝残余体积,并通过影像学评估FLR引流的完整性。使用逻辑回归分析制定死亡风险评分。

结果

90天术后死亡率为14%,年龄(每10岁比值比[OR]=2.1)、术前胆管炎(OR=4.1)、FLR体积<30%(OR=2.9)、门静脉重建(OR=2.3)以及FLR体积<50%的患者中FLR引流不完全(OR=2.8)可独立预测术后死亡。风险评分显示出良好的区分度(自抽样验证后曲线下面积=0.75),将患者按三分位数排序可确定3个(即低、中、高)风险亚组,预测死亡率分别为2%、11%和37%。33例FLR体积>50%的未引流患者中未观察到术后死亡,其中包括10例黄疸患者(中位胆红素水平11mg/dL)。

结论

可切除PHC患者的死亡风险评分可用于患者咨询和确定可改变的风险因素,这些因素包括FLR体积、FLR引流状态和术前胆管炎。我们没有发现证据支持FLR体积>50%的患者进行术前胆道引流。

相似文献

1
Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant.肝门部胆管癌肝切除术后的死亡率:风险评分的制定及未来肝残余量胆汁引流的重要性
J Am Coll Surg. 2016 Aug;223(2):321-331.e1. doi: 10.1016/j.jamcollsurg.2016.03.035. Epub 2016 Apr 5.
2
Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.术后肝功能衰竭风险评分:识别可从门静脉栓塞中获益的可切除肝门部胆管癌患者。
J Am Coll Surg. 2017 Sep;225(3):387-394. doi: 10.1016/j.jamcollsurg.2017.06.007. Epub 2017 Jul 4.
3
Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma.术前胆管炎和未来肝残余体积决定肝门部胆管癌切除术患者肝衰竭的风险。
J Am Coll Surg. 2016 Jul;223(1):87-97. doi: 10.1016/j.jamcollsurg.2016.01.060. Epub 2016 Feb 13.
4
Biliary Drainage Before and After Liver Resection for Perihilar Cholangiocarcinoma.肝门部胆管癌肝切除术前及术后的胆汁引流
Am Surg. 2020 Jun;86(6):628-634. doi: 10.1177/0003134820923287.
5
Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.肝门部胆管癌的现代检查与扩大切除术:荷兰癌症研究所的经验
Langenbecks Arch Surg. 2018 May;403(3):289-307. doi: 10.1007/s00423-018-1649-2. Epub 2018 Jan 19.
6
Insufficient future liver remnant and preoperative cholangitis predict perioperative outcome in perihilar cholangiocarcinoma.未来肝剩余量不足和术前胆管炎可预测肝门部胆管癌的围手术期结局。
HPB (Oxford). 2021 Jan;23(1):99-108. doi: 10.1016/j.hpb.2020.04.017. Epub 2020 Jun 13.
7
Preoperative course of patients undergoing endoscopic nasobiliary drainage during the management of resectable perihilar cholangiocarcinoma.接受内镜鼻胆管引流术的可切除肝门周围胆管癌患者的术前病程。
J Hepatobiliary Pancreat Sci. 2019 Aug;26(8):341-347. doi: 10.1002/jhbp.640. Epub 2019 Jul 9.
8
Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage.肝门部胆管癌的术前胆道引流:识别内镜引流失败后需要经皮引流的患者。
Endoscopy. 2015 Dec;47(12):1124-31. doi: 10.1055/s-0034-1392559. Epub 2015 Sep 18.
9
External biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage.肝门部胆管癌肝大部切除术后的外引流:对肝衰竭和胆漏发生的影响
HPB (Oxford). 2016 Apr;18(4):348-53. doi: 10.1016/j.hpb.2015.11.007. Epub 2016 Feb 18.
10
Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.经皮胆道引流与内镜引流在肿瘤学方面劣势的验证:可切除肝门部胆管癌的倾向评分匹配分析
Surgery. 2017 Feb;161(2):394-404. doi: 10.1016/j.surg.2016.08.008. Epub 2016 Oct 4.

引用本文的文献

1
Perihilar cholangiocarcinoma: a surgeon's perspective.肝门部胆管癌:外科医生的视角
ILIVER. 2022 Apr 5;1(1):12-24. doi: 10.1016/j.iliver.2022.03.004. eCollection 2022 Mar.
2
Intraoperative blood loss in perihilar cholangiocarcinoma: should we aim below a certain cut-off?肝门部胆管癌术中失血:我们是否应将目标设定在某个阈值以下?
Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):279-281. doi: 10.21037/hbsn-2024-677. Epub 2025 Mar 25.
3
Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience.肝门部胆管癌切除术后改善的预后:27年经验
Ann Surg Oncol. 2025 Jun;32(6):4352-4362. doi: 10.1245/s10434-025-17075-5. Epub 2025 Feb 25.
4
Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort.国际多中心队列研究中肝门部胆管癌切除术后的未挽救情况
Ann Surg Oncol. 2025 Mar;32(3):1762-1768. doi: 10.1245/s10434-024-16293-7. Epub 2024 Oct 15.
5
Risk model for morbidity and mortality following liver surgery based on a national Japanese database.基于日本全国数据库的肝脏手术后发病和死亡风险模型。
Ann Gastroenterol Surg. 2024 Apr 16;8(5):896-916. doi: 10.1002/ags3.12803. eCollection 2024 Sep.
6
Successful intrahepatic cholangiocarcinoma conversion surgery after administration of fibroblast growth factor receptor inhibitor.纤维母细胞生长因子受体抑制剂治疗后成功进行肝内胆管细胞癌转化手术。
Clin J Gastroenterol. 2024 Oct;17(5):936-942. doi: 10.1007/s12328-024-02014-w. Epub 2024 Jul 10.
7
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease.比较不可切除局部疾病行 R1 切除与姑息化疗后肝门部胆管癌的生存情况。
Ann Surg Oncol. 2024 Oct;31(10):6495-6503. doi: 10.1245/s10434-024-15582-5. Epub 2024 Jun 19.
8
Outcome of patients with perihilar cholangiocarcinoma and previous biliary instrumentation: an observational study.既往胆道器械操作的肝门部胆管癌患者的预后:一项观察性研究。
BMC Gastroenterol. 2024 May 24;24(1):181. doi: 10.1186/s12876-024-03241-8.
9
Inside stent placement is suitable for preoperative biliary drainage in patients with perihilar cholangiocarcinoma.支架置入术适用于肝门周围型胆管癌患者的术前胆道引流。
BMC Gastroenterol. 2024 May 20;24(1):174. doi: 10.1186/s12876-024-03266-z.
10
Dynamic three-dimensional liver volume assessment of liver regeneration in hilar cholangiocarcinoma patients undergoing hemi-hepatectomy.肝门部胆管癌患者半肝切除术后肝再生的动态三维肝脏体积评估
Front Oncol. 2024 Apr 19;14:1375648. doi: 10.3389/fonc.2024.1375648. eCollection 2024.

本文引用的文献

1
Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections.未来肝残余体积分析技术的比较:对肝大部切除术的意义
HPB (Oxford). 2015 Dec;17(12):1051-7. doi: 10.1111/hpb.12480. Epub 2015 Sep 16.
2
Preoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial.术前内镜下与经皮经肝胆道引流治疗潜在可切除的肝门部胆管癌(DRAINAGE试验):一项随机对照试验的设计与原理
BMC Gastroenterol. 2015 Feb 14;15:20. doi: 10.1186/s12876-015-0251-0.
3
Estimates of absolute treatment benefit for individual patients required careful modeling of statistical interactions.对个体患者绝对治疗获益的估计需要对统计相互作用进行仔细建模。
J Clin Epidemiol. 2015 Nov;68(11):1366-74. doi: 10.1016/j.jclinepi.2015.02.012. Epub 2015 Feb 27.
4
"Surgeons' intuition" versus "prognostic models": predicting the risk of liver resections.“外科医生的直觉”与“预后模型”:预测肝切除术的风险。
Ann Surg. 2014 Nov;260(5):923-8; discussion 928-30. doi: 10.1097/SLA.0000000000000961.
5
Liver planning software accurately predicts postoperative liver volume and measures early regeneration.肝脏规划软件能准确预测术后肝脏体积并测量早期肝脏再生情况。
J Am Coll Surg. 2014 Aug;219(2):199-207. doi: 10.1016/j.jamcollsurg.2014.02.027. Epub 2014 Mar 27.
6
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
7
Communication in the operating theatre.手术室中的沟通。
Br J Surg. 2013 Dec;100(13):1677-88. doi: 10.1002/bjs.9332.
8
Public reporting of surgeon outcomes: low numbers of procedures lead to false complacency.外科医生手术结果的公开报告:低数量的手术导致虚假的自满。
Lancet. 2013 Nov 16;382(9905):1674-7. doi: 10.1016/S0140-6736(13)61491-9. Epub 2013 Jul 5.
9
Novel prognostic scoring system after surgery for Klatskin tumor.肝门部胆管癌术后新型预后评分系统
Am Surg. 2013 Jan;79(1):90-5.
10
Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma.多中心欧洲研究术前胆汁引流治疗肝门部胆管癌。
Br J Surg. 2013 Jan;100(2):274-83. doi: 10.1002/bjs.8950. Epub 2012 Nov 2.